Invest in the best stock opportunities right now and every-time.
Start Systematic Stock Investing ...in less than a minute.
Worth Seeing!
Raymond Moses: Unleashing the Financial Potential of Billions!
Prevest Denpro is currently trading at Rs. 353.95, up by 27.90 points or 8.56% from its previous closing of Rs. 326.05 on the BSE.
The scrip opened at Rs. 377.00 and has touched a high and low of Rs. 377.00 and Rs. 336.60 respectively. So far 8000 shares were traded on the counter.
The BSE group 'M' stock of face value Rs. 10 has touched a 52 week high of Rs. 478.15 on 04-Jan-2022 and a 52 week low of Rs. 170.65 on 01-Oct-2021.
Last one week high and low of the scrip stood at Rs. 377.00 and Rs. 290.00 respectively. The current market cap of the company is Rs. 408.34 crore.
The promoters holding in the company stood at 73.60%, while Institutions and Non-Institutions held 2.00% and 24.40% respectively.
Prevest Denpro has received U.S. Food and Drug Administration’s (USFDA) clearance for four of its products falling in the category of Dental Cavity Liners. Prevest DenPro is the first Indian dental manufacturer who has received USFDA clearance for its products. The products which have been recently cleared in the category of Cavity Liners are CalUltra, Cal LC, Apacal ART and Calcigel. All these products are calcium hydroxide based cavity liners, highly useful for endodontic treatment worldwide.
With the approval of these products company’s product portfolio has widened and company has better marketing prospects in the USA market. As an organization committed to expand its market globally, this approval will enable to serve the international market especially US Market with a bigger product portfolio. The approval is also an endorsement of commitment to comply with global manufacturing standards and regulations.
Prevest Denpro manufactures and markets a range of dental materials for diagnosing, treating, and preventing dental conditions and improving the aesthetics of the human smile.
| Company Name | CMP |
|---|---|
| Poly Medicure | 2880.00 |
| Hemant Surgical Inds | 143.10 |
| Nureca Ltd. | 293.25 |
| Prevest Denpro | 552.00 |
| Centenial Surgical | 128.10 |
| View more.. | |
MoneyWorks4Me rating and ranking of funds for SIP is available to subscribers only. Moneyworks4Me is not a rating and ranking agency, however it is required that users have a way of selecting funds and building a Portfolio. The method used by it are described below to enable users to understand the logic behind the rating and ranking Subscriber will find more details on this in the various content made available from time to time. In case you need more please write to besafe@moneyworks4Me.com
MoneyWorks4Me rates and ranks mutual funds based on the following data-driven system:
Funds ranking in screeners: Performance Consistency and Quality are two parameters used for ranking funds for SIP. The ranking as follows GG, GO, GR, OG, OO, OR, RG, RO and RR.
With the same color-coded funds, the one with the higher Average 3-year rolling returns (over 5 to 10 years), the number that appears in the Performance tag, ranks higher.
Here is the summary:
The third tag Upside Potential is not relevant for SIP. It is relevant for lumpsum investments in Mutual Funds.
Make an informed decision for Stocks
Buy quality Stocks when they are available at reasonable prices and supported by an upward price trend and Sell when they are Overvalued using the Decizen Rating System. Covers 3500+ stocks
Download APP
